After completing a comprehensive review, Cboe is realigning its portfolio of businesses to sharpen its strategic focus on core strengths and emerging growth opportunities. This includes: Initiating a sales process for Cboe Australia and Cboe Canada; Discontinuing U.S. and European Corporate Listings efforts; Reducing costs related to U.S. and European ETP Listings businesses, Cboe Europe Derivatives, and several of Cboe’s smaller Risk and Market Analytics businesses. “This strategic realignment of our business portfolio and human capital ensures Cboe is well positioned to succeed in a dynamic and evolving market and supports our long-term vision to be a global derivatives leader. With strong momentum, as demonstrated from our results this year, and a clear direction, we’re confident in our ability to drive transformative growth and long-term value for shareholders,” said Craig Donohue, Cboe Global Markets (CBOE) CEO.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CBOE:
- Cboe Global Markets reports Q3 adjusted EPS $2.85, consensus $2.53
- Cboe Global Markets sees FY25 revenue up in the low double-digit to mid-teens
- Cboe Global Markets (CBOE) Q3 Earnings Cheat Sheet
- Cboe Global Markets price target lowered to $260 from $261 at BofA
- Cboe Global Markets price target raised to $270 from $265 at Piper Sandler